The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...

Dr Reddy's, Merck Serono in pact to develop biotech drugs Germany's Merck KGaA, have entered into a partnership to co-develop a portfolio of biosimilar compounds (biotechnology drugs) in the ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a ...

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma giant to sidestep over 200 complaints alleging the ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

"This collaboration highlights EMD Serono's commitment to digital-first patient engagement, ensuring that individuals living with HIV have access to proactive and personalized health support ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...